Marketed tadalafil
20 mg PDE5 inhibitor component
Content and sources reviewed
Combination product · evidence limits visible
Super Tadalis SX
Marketed as one tablet containing tadalafil 20 mg plus dapoxetine 60 mg. The pack combines two active ingredients, but ingredient-level evidence does not establish the safety, quality or suitability of this exact fixed-dose product.
The marketed combination
The supplied pack reference identifies tadalafil 20 mg plus dapoxetine 60 mg in one tablet. Tadalafil is a PDE5 inhibitor used for erectile dysfunction; dapoxetine is a short-acting SSRI licensed in some countries for diagnosed premature ejaculation.
Those separate ingredient uses do not automatically validate this fixed-dose brand. We did not find a public regulator-approved dossier for Super Tadalis SX, and a product photograph cannot authenticate a batch, its contents or its supply chain.
Super Tadalis SX at a glance
Pack proposition versus established ingredient context.
Marketed dapoxetine
60 mg short-acting SSRI component
Format
Single fixed-dose combination tablet
Evidence limit
No public product-specific clinical dossier identified
Interaction burden
Nitrates, serotonergic medicines, alcohol and cardiovascular factors all matter
Supply limit
Packaging appearance cannot verify an individual pack or batch
How the related products differ
| Product | Marketed contents | Main proposition | Key evidence question |
|---|---|---|---|
| Tadalis SX | Tadalafil 20 mg | Longer tadalafil opportunity window | Single-ingredient product still needs pack verification |
| Super Tadalis SX | Tadalafil 20 mg + dapoxetine 60 mg | ED and PE positioning in one tablet | Fixed-dose combination safety and suitability are not established by ingredient evidence alone |
| Super Kamagra | Sildenafil 100 mg + dapoxetine 60 mg | Shorter-acting PDE5 inhibitor plus dapoxetine | Different PDE5 ingredient, with the same combination-evidence concern |
Core sources
- NHS: Tadalafil
Tadalafil uses, dosing context, duration, nitrate warning, interactions and side effects.
- NICE: Premature ejaculation — dapoxetine evidence summary
Licensed dapoxetine dose sequence, adverse-event data, contraindications and the PDE5-inhibitor combination warning.
- PharmaCity: tadalafil with dapoxetine listing
Commercial evidence that a 20/60 mg ingredient-equivalent listing exists; not a regulator dossier or authentication of Super Tadalis SX.
Super Tadalis SX questions
Is Super Tadalis SX simply stronger Tadalis SX?
No. Tadalis SX is marketed as tadalafil alone. Super Tadalis SX adds dapoxetine, a different drug class with its own contraindications, interactions and dose sequence.
Why does the 60 mg dapoxetine dose matter?
Licensed dapoxetine guidance commonly starts at 30 mg and only considers 60 mg after response and tolerability are assessed. The fixed-dose product begins at the higher dapoxetine strength.
Does tadalafil still have an opportunity window up to 36 hours?
That is established tadalafil ingredient context. It does not prove how this exact fixed-dose formulation performs or whether it is suitable for an individual.
Can it be taken with nitrates or poppers?
No. Tadalafil and nitrates can cause a dangerous fall in blood pressure. Dapoxetine also adds serotonergic, fainting and alcohol-related cautions.
Does the product image prove authenticity?
No. The image is an AI-generated illustration based on the supplied pack photograph. Neither an image nor familiar packaging can verify contents, registration or a batch.
View the ingredient-equivalent partner listing
The sponsored link goes to a third-party tadalafil 20 mg plus dapoxetine 60 mg listing, not a verified Super Tadalis SX product page. The partner controls its listing, availability, checkout, fulfilment and terms.